Trxade Health Profit Margin

Trxade Health (MEDS) currently reports a profit margin of -9204.6% as of March 2026. That compares with 9830.92% in the prior-year period — down 193.6% year over year. That is below the Finance sector average of 17.18%. Use the charts on this page to explore Trxade Health's profit margin history and peer comparisons.

Trxade Health's profit margin decreased from 9830.92% to -9204.6% — a 193.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Trxade Health's profit margin of -9204.6% is lower than the Finance sector average of 17.18%. That is roughly 53685.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Trxade Health's current -9204.6% should be judged against Finance norms (sector average: 17.18%) and against MEDS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -9204.6%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Finance average is 17.18%. From there, open related valuation or income-statement pages for Trxade Health, and consider following MEDS for alerts when major investors trade the stock.